Suranganie F. Dharmawardhane

San Juan, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment.

Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment.

Journal: Cancer treatment and research communications

Published: June 22, 2026

M6 metabolite contributes to the efficacy of the Rac/Cdc42 inhibitor MBQ-167 in metastatic breast cancer.

M6 metabolite contributes to the efficacy of the Rac/Cdc42 inhibitor MBQ-167 in metastatic breast cancer.

Journal: Molecular cancer therapeutics

Published: November 03, 2025

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer.

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer.

Journal: Translational oncology

Published: December 16, 2023

Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Journal: Molecular cancer therapeutics

Published: November 15, 2023

Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.

Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.

Journal: Cancer research communications

Published: March 02, 2023

Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.

Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.

Journal: Frontiers in oncology

Published: January 27, 2023

Soy and Frequent Dairy Consumption with Subsequent Equol Production Reveals Decreased Gut Health in a Cohort of Healthy Puerto Rican Women.

Soy and Frequent Dairy Consumption with Subsequent Equol Production Reveals Decreased Gut Health in a Cohort of Healthy Puerto Rican Women.

Journal: International journal of environmental research and public health

Published: June 15, 2021

Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.

Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: April 20, 2021

Rho Family GTPases in Cancer.

Rho Family GTPases in Cancer.

Journal: Cancers

Published: February 20, 2021

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.

Journal: BMC cancer

Published: September 26, 2020

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice.

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice.

Journal: Pharmaceutics

Published: September 20, 2020

Targeting Rac and Cdc42 GEFs in Metastatic Cancer.

Targeting Rac and Cdc42 GEFs in Metastatic Cancer.

Journal: Frontiers in cell and developmental biology

Published: February 03, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026